Stay updated on Soticlestat in Rare Epilepsies Clinical Trial
Sign up to get notified when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.
Latest updates to the Soticlestat in Rare Epilepsies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now renders a 403 Forbidden error with a minimal header and a Home link, replacing the previous study record content. This indicates restricted access to the study details and shows basic site chrome instead of study information.SummaryDifference19%
- Check19 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a new deployment version. This appears to be a backend/template update rather than a change to study content or user-facing information.SummaryDifference0.0%
- Check26 days agoChange DetectedThe study record now includes a sponsor note that Takeda divested TAK-935-18-001 to Mistrau Bio, Inc. in 2026, and adds/updates the Study Director and Investigators sections with corresponding dates.SummaryDifference0.4%
- Check33 days agoChange DetectedThe site revision has been updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor platform update rather than a change to study content or functionality.SummaryDifference0.0%
- Check40 days agoChange DetectedThe page now includes a 2018 U.S. NIH Grant/Contract entry under Other Study ID Numbers. This addition provides funding attribution for the ENDYMION 1 study.SummaryDifference0.1%
- Check47 days agoChange DetectedNo additions or deletions were reported for this page in the provided changes feed, so the content remains unchanged based on the available data.SummaryDifference0.1%
Stay in the know with updates to Soticlestat in Rare Epilepsies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.